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SUMMARY.
Prior to 1986, Sowetan children were vaccinated against measles on 
two occasions at 6 and 12 months of age. In order to comply with 
the World Health Organisation's recommendation for African 
countries, this schedule was changed in January 1986 to one 
vaccination at 9 months of age.
At the time of this change in the measles vaccination schedule, 
there was a reported increase m  the incidence of measles at
hospitals that serve the population of Soweto. This was thought to 
represent a general increase in the incidence of measles in
Soweto.
This study set out to investigate this reported increase in the 
incidence of measles over the period. A retrospective record review 
of notification forms was undertaken.
The results showed that the incidence of notified measles cases in 
1986, compared with 1984 and 1985, had not increased. However the 
median age at which children presented with measles had decreased 
from over 40 months in 1984/85 to 24 months in 1986.
In addition the peak in the age specific attack rate had changed 
in the period under review from over one year of age in 1984/85 to 
less than one year in 1986. More cases were notified from hospitals 
in 1986 than in 1984 and 1985.
Population migration of unvaccinated children into Soweto appeared 
to account for up to 100 per cent of cases in certain districts. 
This emphasises the need for the implementation of a national 
strategy for measles prevention in order to protect all children. 
Awareness programmes directed at mothers to promote measles 
vaccination and to remind health care professionals of the legal 
requirements to notify measles cases would help to control the 
spread of measles and would provide an assessment of the full 
extent of the problem.
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01. INTRODUCTION.
In order to give background to the study a literature review was 
undertaken which encompasses measles the disease, its complications 
and preventive strategies. The cost efficiency of the vaccine, 
international experience and the optimal age of vaccination are 
discussed. To end the introduction the health service in Soweto is 
reviewed.
1.1. MEASLES IN DIFFERENT COUNTRIES.
Measles is a major global problem deserving the attention of all 
nations since it is an important cause of infant and child 
morbidity and mortality, particularly in the developing world.(1) 
The measles virus is very infectious. In Greenland Christensen 
found that 99.9% of a previously unvaccmated, unexposed population 
developed measJes when the wild virus was reintroduced.(2)
The impact of measles measured by surveillance data on morbidity 
and mortality, and range and severity of complications is extremely 
variable from country to country.(3,4)
Before the introduction of measles vaccine in the United States of 
America, the highest case-fatality rates were in the very young 
and in the children with low socioeconomic status.(5)
Since the introduction of measles vaccine the impact of measles 
has been greatly reduced, as is the case reported from North 
America and certain Central and South American countries such as 
Cuba, Chile and Costa Rica.(3)
Measles is widely recognised to be a severe illness in the 
developing world; Ghosh and Dhatt in Madras in 1969 considered 
measles to be more serious than diphtheria.(6) In developing 
countries, some epidemics have killed one fifth or more of the 
population previously unexposed.(4)
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Measles is more severe m  countries where childhood malnutrition 
is common.(7) It has been postulated that the severity in 
developing countries is related to both the young age at which 
measles is usually contracted and the high prevalence of 
malnutrition. ( 8 )
In India, it is thought that "the impact of measles in the 
overcrowded, expanding, turbulent cities is often underassessed 
while the fatalistic attitude in the rural areas makes control more 
difficult."(3)
In Africa, measles remains a problem. It is an important cause of 
morbidity and mortality, particularly among socioeconomically 
deprived communities. Respiratory complications and diarrhoea are 
relatively common during and following measles infections. The 
case-fatality rate for all children in developing countries is 
estimated to be 1 to 5%. However, the true level of mortality 
attributable to measles in developing countries in Africa, although 
thought to be high, is unknown.(9,10,11)
1.2. MEASLES IN SOUTH AFRICA.
South Africa has reported severe outbreaks of measles during the 
past two centuries.(12,13,14) During 1985, at least 2428 patients 
with measles were admitted to two hospitals in Natal. The mortality 
rate among these patients was 14,7%.(15) At Baragwanath hospital, 
from January 1987 to July 1987, measles accounted for 5,8% of all 
paediatric admissions, compared with 1,6% in 1982. (16) Thirty six 
percent of these children were 9 months of age or less. (16) During 
the same period, from January to July 1987, measles in children 9 
months or younger accounted for 27,2% of measles admissions in Cape 
Town(17) and between 20 and 45% of measles admissions in Natal.(18)
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1.3. Measles and its complications.
In developed populations measles is often considered a mild disease 
of childhood.
In Europe and America a proportion of non immunised children do 
not appear to contract measles after exposure. It was reported from 
Britain that 15% of children escape attack after exposure.(19) 
These children may have had a subclinical attack of measles.
In East Africa 25% of unvaccinated children 1 year of age with no 
previous history of clinical measles had antibodies.(20) In New 
York, Krugman showed that while the haemagglutonin inhibition (HI) 
antibody level declined to 1:8 by 1 year of age, in a few infants, 
the HI level suddenly rose during the period 6 months to 1 
year.(21) These children experienced a subclinical infection in 
the period of decline in the maternal antibodies.(4)
Subclinical infections occur in this age group only in areas where 
the disease is endemic.(4)
However, the necessity to control and eradicate measles is better 
appreciated when the extent and severity of the morbidity and 
mortality in developing populations is understood.
Many of the complications of measles eventually require hospital 
admission. (22,23,24) Factors which seem to underlie the unusual 
severity of the disease in Africa are malnutrition, a lower mean 
age of incidence of disease during epidemics, the extremely high 
rate of secondary pyogenic infections, involving the skin and the 
respiratory tract, and the frequency of stomatitis and diarrhoea 
inducing dehydration.(22)
j/ 1.3.1 Malnutrition.
Malnutrition in children can aggravate or be aggravated by measles 
infection.
Measles in malnourished children differs markedly from the disease 
as usually seen in well nourished children.(22)
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Dosseter et al have said that malnutrition depresses immunity which 
leads to prolonged measles infection and further damage to the 
immune system.(25) The nutritional status of the child before and 
during the attack of measles is the dominant factor in producing 
the severe form of the disease.(4) In Nigeria measles is the acute 
infection most likely to precipitate acute kwashiorkor in 
children.(26) Following measles infection children have been 
reported to lose up to 10% of their body weight.(26) In Kenya, the 
severely malnourished patients suffered a more prolonged and 
complicated illness than the well nourished. These patients 
suffered an average of four complications, 70% had severe 
stomatitis and 77% had diarrhoea.(27) In India, among children 
hospitalised with measles, 89% of those poorly nourished had more 
than one complication e.g. pneumonia, otitis, stomatitis or 
diarrhoea, while only 20% of the well nourished had more than one 
complication.(28)
Measles in the poorly nourished results in severe changes of the 
mucous membranes of the mouth, tracheal-bronchial tree, and 
intestine.(22) The inflammatory process of the mucous membrane of 
the intestine leads to a protein-losing enteropathy.(23,24) In 
Guatemala, Scrimshaw et ai noted that diarrhoea was three times 
more frequent among those poorly nourished.(29) Diarrhoea 
associated with measles is recognised as a danger for dehydration 
and increased mortality.(30) Often oral rehydration therapy is not 
adequate and parenteral fluid replacement is required. Death 
following diarrhoeal complications of measles occurs in both well 
and malnourished children and is associated with a variety of 
pathogens.(22 ) Measles associated with prolonged diarrhoea of more 
than 7 days duration significantly increases the risk of 
mortality.(31)
Foster reported that children below the weight for height Harvard 
standard who survive, recover slowly and catching up weight can 
take longer than 3 months.(32)
6Children with more severe skin lesions tend to develop sequelae to 
measles, it has been suggested that this is because of the lack of 
some nutrient or nutrients which may cause a greater degree of 
perivascular extravasation, producing a darkening of the rash of 
the skin and exfoliation. Equivalent changes in the epithelium of 
other organs cause other complications.(4) This association between 
a darkened rash and the severity of the disease was recognised as 
long ago as A.D.85U by the Arabian physician Rhazes.(33)
1.3.2. Secondary infections.
The depressed cellular immune system increases patients' 
susceptibility to secondary infections.(34) Studies have shown that 
gamma interferon produced mainly by T lymphocytes is reduced in 
patients with measles.(35)
It has been reported that a profound lymphopenia (<2,000 
lymphocytes/ ml.) during the exanthem stage distinguished those 
African children who subsequently died or developed chronic chest 
disease from those who recovered.(36) In these children an excess 
of HLA-AW32 (histocompatibility antigen) has been found compared 
with controls.(37)
For up to five weeks following measles infection, a child has an 
increased susceptibility to intercurrent infections with both viral 
and bacterial organisms.(38 ) Adeno type 2,3, and 7 and herpes viral 
infections are the most prevalent.(3)
Other viral infections are caused by cytomegaio, para influenza, 
respiratory syncytial and coxsackie viruses.(39) Bacterial 
infections are less common and therefore secondary infections that 
occur during the acute attack of measles are usually viral and 
hence not responsive to antibiotic treatment.(3)
7Both laryngitis with airway obstruction and bronchial pneumonia 
are relatively common sequelae of measles in West Africa.(4)
The latter is a common, serious complication of measles often 
necessitating hospitalisation.(4)
Pneumonia has been found to be the commonest lethal complication 
of measles. (39) The pneumonia is usually divided into early and 
late onset pneumonia.(22) Giant cell pneumonia caused by the 
measles virus typically begins early in the course of the illness 
before the rash fades. More frequently, the pneumonia appears after 
the initial symptoms of measles have subsided.(22) This late on­
set type is usually caused by viruses other than the measles 
virus.(22) Bacteria are seldom the cause of pneumonia.(22) At 
autopsy, of 18 coloured and black toddlers from South Africa who 
died from pneumonia following measles, it was shown that adeno 
virus, measles virus and herpes virus caused more than half of the 
late on-set pneumonias.(40 )
In Columbia, Dover performed lung punctures before antibiotic 
therapy was commenced on 15 children with late onset pneumonia, 
the cultured samples yielded bacteria in only two cases.(39) 
Measles may also activate a primary tuberculous lesion in the 
lung.(41)
Conjunctivitis with involvement of the conjunctival sac is common 
and measles may lead to damage or destruction of one or both 
eyes.(4) Xerophthalmia that results in blindness occurs in areas 
of the world, where diets are deficient in vitamin A.(4) In these 
areas, for example Kenya and Indonesia, more than half of the 
incidence of blindness may be attributable to measles.(4,42,43)
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1.3.3. Associated neurological conditions.
There is an hypothesis that a host cell-dependent lack of synthesis 
of M protein in the brains of patients following measles infection 
may be the cause of subacute sclerosing panencephalltis.(SSPE).(36) 
A few children ( 0.5-l.t) per 100 0 00) develop SSPE on average 7 
years after clinical measles infection.(44) Another chronic 
neurologic disease linked largely by indirect evidence to measles 
virus is multiple sclerosis (MS).(45,4b)
Increased levels of measles virus-specific immunoglobulin have been 
demonstrated in the cerebrospinal fluid (CSF) of '50% of patients 
with MS, and in the CSF of a smaller percentage of patients with 
other neurologic disease.(47,48)
The low serum to CSF antibody ratios recorded have led to the 
suggestion that the antibodies in the CSF of MS patients is 
produced within the central nervous system.(49) Demographic and 
epidemiological studies have proposed an hypothetical incubation 
period of about 15 years for MS.(50) If infection with wild measles 
virus, but not with vaccine virus is in any way responsible for MS, 
a reduction in the incidence of this disease should occur in those 
countries that have promoted measles vaccination for the past 
decade or longer.(36)
Encephalitis and convulsions, following measles, have been 
described from West Africa. One and a half percent of admissions 
gave a history of convulsions and 2.5% developed them after 
admission. Mortality in these children is high.(51)
1.3.4. Mortality.
Case fatality rates vary in different parts of the world. Epidemics 
in the Andean Spanish colonies in South America in 1531 recorded 
mortalities higher than 50%.(52)
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A distinction is made between death durinq the acute phase and 
deaths during the 9 months after the acute phase of measles. During 
the acute phase of the disease, case fatality rates in the 
community may range from U.9% to 36%. (53,54) it would seem that 
the mortality in the period 3 to 9 months following the acute 
attack, is as high as during the acute phase. Some reports show 
that more than half the deaths after measles occurred in the period 
3 to 9 months after the outbreak.(54)
Some variables that influence mortality due to measles are: The 
size of the family, the nutritional status of the child during the 
attack, the occurrence of secondary infections and the age of onset 
of measles.(4) In large families, mortality rates are high in 
young children, especially if they are secondary cases.(55) It was 
hypothesised that measles resulted in a significant weight loss, 
immunosuppression, or both, which in turn increased mortality in 
measles cases from undernutrition, malaria, diarrhoea, or other 
infectious diseases.(54)
Roster in Bangladesh found that measles and diarrhoea acted 
synergistically to increase mortallty.(56) During the Nigerian 
Civil War observations made at a time of severe famine revealed 
that up to 15% of those in a medical centre for the treatment of 
kwashiorkor died.(57) In Indonesia Foster reported that only 10% 
of hospitalised children above the Harvard standard of weight for 
age died, while 18% of those below this standard died.(32)
The case fatality rate from measles was 2.3 times greater among 
severely malnourished children than among better nourished 
children, while in Bangladesh, it was 4.3 times higher.(28)
Variation in virus virulence does occur.(4) Hospital acquired 
measles is particularly severe with a high case fatality rate. 
(58,59)
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^  1.4. THE SPREAD OF MEASLES.
Measles virus spreads within populations by the infection of a 
series of susceptible individuals. E'or the virus to remain endemic, 
there must be a constant influx of susceptibles, provided by birth 
or immigration.(10) The most common route of transmission of the 
virus from one individual to another involves both direct and 
indirect contact via respiratory droplets.(22) Those in close 
proximity to the source inhale the virus. It multiplies and 
invades the tissues of the susceptible host.
The most infectious stage of the disease is from the onset of 
fever, before the rash appears on the fourth day, until 2 days 
after the rash has appeared.
In well nourished children viral excretion continues for 3 days. 
In malnourished children, viral excretion can continue for up to 
three weeks. The persistence of the virus in lymphocytes and 
intestinal cells suggests that there is a delay in the production 
of lymphocytes that are competent to destroy these cells. As a 
result, the virus multiplies for a longer period, more cells are 
infected, and the disease is more severe. In addition, the 
depressed cellular immune system increases the susceptibility to 
spread the infection.(25)
Therefore in areas of poor nutrition, as is the case in some areas 
of Soweto, the likelihood of viral transmission from convalescent 
patients may increase.(25,5b) Patients who have been admitted to 
hospital with poor nutrition should remain in isolation for at 
least three weeks following recovery.
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1.4.1 Hospitals and clinics and the spread of measles.
Cross infection in hospitals and clinics is promoted by the close 
proximity of patients in these institutions.(bU) Over a 16 month 
period, 77 consecutive cases of life threatening measles cases were 
admitted to the Red Cross War Memorial Children's Hospital 
intensive care unit. Twenty of these 77 probably caught the disease 
while in hospital.(61)
It has been suggested that, in the case of infection with measles, 
the crowding dose appears to be more important in promoting a 
severe form of the disease than the patient's resistance.(62)
1.4.2. Social factors predisposing to spread.
An outbreak of measles may be precipitated by social events, 
particularly after the population has congregated for some or other 
reason. For example, at the beginning of a school term, or for a 
celebration. In Nigeria during the dry season following harvests 
when many markets and festivals occur, transmission is greater.(63)
In large families the average age for contracting measles is lower, 
than in small families consisting of 1 or 2 children, probably 
because the opportunities for introducing the virus into the family 
are so much greater. (64) When the virus is introduced into a 
family, it spreads rapidly and almost all those not yet immune 
develop the disease. Hope Simpson observed a secondary attack rate 
of 75% among large families.(65) The large, and extended families 
that are common in developing populations increase the opportunity 
for contact and viral transmission.(22)
Similarly in cities, where contact among many children is common, 
the average age of acquisition of measles is generally lower than 
in rural areas.(22)
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1-5. The measurement of measles
Under notification for measles is a universal problem.(66)
Only health workers are presently allowed to document and notify 
measles. Alternative methods need to be considered. The initial 
notification of a suspected case of measles should be made simple 
and need not necessarily be made by health workers only. Who 
should be allowed to notify?; and whether telephonic notifications 
should be acceptable? are questions posed in the literature and may 
be considered for Soweto.(16) With minimal training notifications 
can be made by medically unskilled people. In The Gambia, use was 
made of village elders to report on the progression of the outbreak 
of measles and to ensure complete ascertainment of early cases.(9)
Within Soweto this task could be performed by child minders and 
teachers working in creches and at schools. Suspected cases of 
measles could then be referred to the local clinics, community 
health nurses or general practitioners for confirmation of the 
diagnosis.
1.6. NATURAL AND ACQUIRED IMMUNITY OF MEASLES.
1.6.1 The immune response to measles virus.
The natural immune response of people previously unexposed to 
measles is the production of lymphocytes that exhibit measles 
virus-specific antibody and cytotoxic responses.(b7,66) Protection 
by measles specific, cell mediated response in the absence of 
antibody has been reported.(69) Some children with 
agammaglobulinemia apparently respond normally to measles
infections in the absence of detectable antibody.(36)
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1.6.2. Variations in host immunity.
Individual variation in host immunity does occur. This is 
independent of the existence of residual maternal antibody, which 
is known to protect young children.(4) The duration of post­
vaccinal immunity beyond one year of age has not been studied, but 
it can reasonably be expected that immunity after one vaccination 
at 7.5 months will last for at least 3-5 years.(70)
The immune status in previously unexposed children that are no 
longer protected by maternal antibody depends upon the 
availability, stability and potency of the attenuated virus 
vaccine, route of administration, timeous age at vaccination, 
adequate seroconversion and any special conditions that might
disrupt the health service and affect compliance, for example 
floods, civil unrest or an inadequate health service to vaccinate 
the community against measles.(4)
The immune status of the population at risk is the important factor 
in preventing cases. It is difficult to decide what constitutes a 
minimum protective level of antibody after vaccination since the 
laboratory tests used in the past have varied widely in sensitivity 
and few have directly measured neutralising antibodies by plaque 
inhibition(PI).(71) Krugman has argued that haemagglutonin 
inhibition(HI) antibody levels following vaccination may decline 
to less than 1:8 or even undetectable levels yet provide clinical 
protection, probably because of the anamnestic response following 
re-exposure to the wild virus.(72)
The detection of measles antibodies.
The discrepancies between various studies for the detection of 
residual maternal antibodies may result because of the first 
dilution at which sera are tested.(73)
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Bass found that two thirds of sera that would have been stated to 
be negative if tested at 1:10 were in fact positive with plaque 
inhibition tests.(74) From results carried out with the classical 
antigen it was generally thought that passive immunity of maternal 
origin was depleted by 6 months of age. However, with the Tween- 
ether antigen, Stanford found that 35% of children in Uganda still 
had detectable antibodies at b months of age.(75) Puffer et al
found that at 6 months of age, at least 20% of children will still 
have maternal antibodies.(23) Following vaccination only 60-80% 
of these children will seroconvert and develop protective 
immunity.(23)
In a collaborative study by the Ministry of Health of Kenya and 
the World Health Organisation it was found that 90% of children no 
longer have maternal antibodies at 7-8 months of age.(70) In this 
study it was precisely at that age that the incidence of measles 
began to rise sharply.(70)
1.7. THE PREVENTION OF MEASLES
1.7.1. The vaccine.
The vaccine is prepared by attenuation of the measles virus. 
Several vaccines have been used to vaccinate against measles,
i. The Edmonston strain; First used about 20 years ago, this has 
undergone 40 passages in cell culture in the process of 
attenuation.(36) In the early 1960's, Spencer, in the Johannesburg 
City Health Department, conducted controlled trials with the Enders 
Edmonston B strain of vaccine under the auspices of the World 
Health Organisation. The aim of the trials was to demonstrate the 
clinical reactions, immunogenic response and protection when 
children 6 months of age were immunised against measles. Following 
the implementation of this programme, some children, who had been 
immunised at six months and were thought to be protected by the 
vaccine, presented with clinical measles.
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This was attributed to the presence of maternal antibodies at the 
time that they were vaccinated which adversely effected 
seroconversion.
ii. The Schwartz strain; It is a derivative of the Edmonston vac­
cine and has undergone 77 passages.(36) It is usually used in 
infants older than 9 months, where optimum seroconversion rates of 
between 85% and. 90% have been reported in Africa.(73,76 )
The Schwartz strain is equally immunogenic but has less adverse 
clinical reactions than the Edmonston strain.
Studies with the Schwartz vaccine have shown that optimum 
seroconversion rates fall sharply if children are immunised earlier 
than 9 months because maternal plaque-neutralising (PN) antibody 
neutralizes the attenuated virus.(36)
iii. The Moraten and Zagreb strains; Both these vaccines are also 
derivatives of the Edmonston strain. Results of reduced 
seroconversion were reported by Parkman and Amler in 1983 for the 
Moraten and Zagreb strains when children less than 9 months of age 
were immunised.
It was shown that the failure rate was between 40-100% when infants 
were immunised with this vaccine at 5 months of age. (77,78) 
However, contrary to these findings Sabin et al, in 1984, found 
that an aerosol of undiluted human diploid cell Zagreb strain 
vaccine, produced almost 100% seroconversion rates in 4-6 month old 
Mexican infants.(80) Administration of this virus by the 
respiratory route has been suggested because the virus replicates 
more readily in the human lung fibroblasts than does the chick- 
cell-adapted Schwarz strain.(79)
In addition, administration via the respiratory route in young 
infants would avoid neutralisation of the vaccine by maternal 
measles antibodies, because maternal measles antibodies are 
immunoglobulin G and therefore not secreted on the surface of the 
infant lung.(71)
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Vaccine aerosol given either by mask in a dose of 3500 or 7000 
plaque forming units(PFU) or from a plastic bag at a dose of 7000 
PFU raised haemagglutonin inhibiting (HI) or plaque-inhibiting 
measles antibodies 16 to 24 weeks after vaccination to a titre of 
1:8 or greater, in all but 3 of the 51 children so vaccinated in 
the Gambia.(71) Aerosol inhaled from a mask or bag was generally 
well tolerated.(71) Children who cried did not have a lower 
antibody response than the others. Human diploid cell vaccines used 
to immunise 4-6 month old infants could thus be conveniently given 
at the same time as the third dose of diphtheria, pertussis, 
tetanus and polio vaccines.(5) This vaccine would be of particular 
use for vaccinating hospitalised infants who may be at high risk 
of developing measles.
In 1983, Sabin et al found that the Edmonston-Zagreb vaccine in a 
dose of 5000 plaque forming units given subcutaneously to 5 month 
old children also produced almost 100% seroconversion.(80) If this 
is so it would be of particular use in community vaccination 
programmes.
1.7.2. Passive immunity.
Passive immunity is available with the use of immune globulin- 
containing measles antibody which provides passive protection 
against clinical measles.(36) This should only be considered for 
those patients who are at risk for developing serious complications 
of measles.
1.8. THE TIMING OF VACCINATION.
The timing of vaccination depends upon the type of vaccine used 
and the method of administration. To date, a derivative of the 
Schwartz vaccine has been in use in Soweto. Before 1986 the policy 
in Soweto was to vaccinate against measles in children at both 6 
and 12 months of age. In 1983 the World Health Organisation (WHO)
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recommended that African countries give one dose of vaccine at the 
age of 9 months. In January 1986, the health authority in Soweto 
implemented this recommendation.
1.8.1. Developed populations.
Presently the WHO recommends that the optimal age for measles 
vaccination in a developed population, using the Schwartz vaccine 
sub cutaneously, is 15 months. This is because maternal antibodies 
have disappeared or are less than 1:6 by then and the population 
has ready access to the health service.
1.8.2. Developing populations.
The optimal age for measles vaccination in a developing population 
is controversial.(54) The vaccination schedule should be based upon 
three sets of basic data: i.the pattern of waning measles maternal 
antibodies during the first year of life;? the efficacy of 
vaccination as determined by age specific seroconversion ratesT>and 
the age specific incidence of measles in the population. Generally, 
a lower age specific attack rate and greater severity of 
complications in a developing population require that children be 
vaccinated against measles at an earlier age, in fact from 6 months 
of age. However, measles vaccination at 6 months instead of at 9 
months is considered less effective because maternal antibody is 
more likely to be present and this reduces seroconversion. 
However, even vaccination at 9 months of age is not ideal as some 
children vaccinated at less than 1 year of age will show no 
detectable haemaglutination inhibition antibody (HI) eight months 
after vaccination.(81)
The detection of antibody is dependent upon the method used.(73) 
For the detection of HI antibodies different results may be 
obtained according to the type of antigen used.(73) Plaque 
inhibition tests are 10 times more sensitive than HI tests. (73)
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1.8.3. Vaccine failure.
Reasons for vaccine failure are:
i. Vaccine administration at too early an age
ii. an inappropriate anatomical site of vaccine administration or 
iii the use of non viable vaccine.
The reasons for 1 and ii above will be discussed in the section on 
the failure to seroconvert.(1.8 . b . )
Vaccine failure due to the inadequate maintenance of the cold chain 
is a problem. This is not quite as critical as it used to be. With 
the advent of the new stabilizers that retard heat inactivation, 
in field trials, >85% of children 9 months of age or older 
seroconverted after receiving vaccine that was stored at 23-25 
degrees Celsius for 7-8 days.(82) However, once the vaccine has 
been reconstituted into a liquid form, it is particularly heat- 
labile. (10) The rehydrated vaccine remains potent for 4-b hours. 
Health workers need to be continually reminded of this, 
in the Soweto clinics electricity and refrigeration facilities are 
available to store vaccines.
Even where the supply of electricity cannot be depended upon, 
technological developments improving refrigeration have made the 
storage of vaccine possible.(83,84,85 )
1.8.4. The clinical complications of vaccination.
The known side effects of measles vaccine are:
a mild fever beginning on the fifth day after vaccination and 
usually lasting several days; a transient rash; encephalitis and 
encephalopathy (in less than 1 per million doses). The latter is 
lower than the observed incidence of encephalitis of unknown 
aetiology in the general population.
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1.8.5. Contraindications and safety precautions for vaccination.
There are few contraindications to vaccination other than age and 
pregnancy. Patients with immune deficiency or altered immune 
response, eg in the auto immune deficiency syndrome, should not be 
immunised. For intercurrent febrile illness, measles immunisation 
should on ly be postponed at the discretion of the physician.(86 )
Moderately malnourished children bl)%-8U% of normal weight for age 
appear to suffer no more untoward effects and to produce as much 
antibody after vaccination as well nourished chiIdren.(87,88) 
There is no direct evidence to implicate vaccine virus in either 
acute measles encephalitis or subacute sclerosing pan encephalitis 
(SSPE).(3b) Attenuated measles virus vaccine has been widely used 
in the United States since 1968.(89)
Studies on patients with cystic fibrosis and with nephrosis have 
shown that they tolerated vaccine well and developed the usual 
serological response.(90)
In both these conditions low serum albumin is found which closely 
parallels the protein deficient Nigerian children.(91) It is 
important to prepare mothers for the possible side effects, at the 
same time ensuring them of the advantages, following measles 
vaccination. This would help to dispel any negative thoughts or 
attitudes that the community might develop towards a reaction 
following measles vaccination.
1.8.6. The failure to seroconvert under 1 year of age.
The initial response to the finding that some children under one 
year of age failed to seroconvert was a suggestion that they be 
revaccinated at 1 year of age. However, vaccination of children 
less than 8 months of age may change the immune response and leave 
all children so vaccinated susceptible to measles.(81)
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In a study done in Los Angeles, only 49% of children responded 
optimally to revaccination.(81) Black et al, workinq in third 
world conditions found that children who failed to seroconvert 
followinq an initial "early" (ie. before 9 months) and second (at 
9 or 12 months) dose of vaccine, had reduced levels of 
haemaqlutination inhibition (HI) antibody titres after several 
months.(64)
The children were considered to be immunoloqically sensitized but 
not immune to infection. What is not clearly understood, at this 
staqe, is what the consequences are for these children when they 
are exposed to natural wild measles virus. The followinq questions 
need to be answered. Are they susceptible? Do they have antibodies 
that are not detectable by a sensitive neutralisation test? Are the 
low or absent HI antibody titres fixed for life? Should these 
children be revaccinated? What are the implications for the immune 
protection of the next qeneration?(92 ) The effect immunoloqically 
sensitised but not immune patients may have on herd immunity and 
ultimately the intention to eradicate measles is of concern. If 
more than 5% of the population are susceptibility to measles then 
they act as a reservoir and keep measles endemic.
Vaccination at 9 months of age has been reported to protect 88% of 
subjects(92) In another study, immunisation at 9 months of age 
protected 9 out of every 10 recipients.(93)
Yet vaccination at 9 months of age is too late to protect a large 
proportion of those children under that age susceptible to measles. 
An additional problem of vaccinating at 9 months of age is the 
problem of failure to seroconvert in the 10% of the population who 
still have maternal antibodies. By 15 months they will be 
unprotected against measles and they will be capable of maintaining 
measles endemicity, even if 100% vaccine coverage has been 
attained.(94)
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A measles vaccination policy that vaccinates after 9 months of age 
in a developing population not only fails to protect a large 
percentage of the population who are to susceptible to measles but 
it also is associated with failure to return for the vaccination 
and this may be as high as 26%, because other vaccinations have 
been completed.(95)
Not all communities should necessarily be vaccinated at the same 
age. For derivatives of the Schwartz vaccine a revised vaccination 
schedule for measles in developing communities should be determined 
by:
the concentration of maternal measles antibodies in infants 3-9 
months of age; and the age specific incidence rate of measles in 
the population.(94) It has been suggested, though, that during 
epidemics children less than 9 months in high risk situations 
should be immunised.(96)
If the effect that the presence of maternal antibodies has on 
patients to seroconvert following measles vaccination could be 
overcome, the ideal age at which to vaccinate against measles would 
be at 6 months together with the diphtheria, pertussis, polio and 
tetanus vaccines. This could be given at maternal and child health 
clinics. If it is given later in life it has been shown that in the 
9-23 month old age group the attendances at mother and child health 
clinics is rapidly falling off.
In The Gambia 15-3U% fewer children attend for measles vaccine at 
9 months than at 5 months, when diphtheria, pertussis, tetanus and 
oral polio vaccine are given.(97)
The current policy, using the Schwartz vaccine, is to vaccinate at 
9 months of age based upon the WHO recommendations. However the new 
strains of vaccine may change this policy.
1.9. THE COST EFFICIENCY OF MEASLES VACCINATION.
In 1983, it was estimated that the cost to vaccinate against 
measles in cities and .large towns was U.S. $2 to 6 (approximately 
R1U) per child.(22) The cost of measles to the community has to be 
considered in terms of direct and indirect costs. Direct costs 
based on expenditure on hospitalisation and vaccination are more 
easily calculated. Indirect costs and benefits are less easily 
quantifiable and include costs of treatment of complications in 
out-patients clinics and of mortality. The saving of lives and the 
avoidance of hospitalisation are sufficient reason to have all 
children immunised against measles.(96)
During January to July 1987 15 patients were admitted to the
Intensive Care at Baragwanath hospital. The mortality was 40%, 
and the financial cost of hospitalisation was calculated to be 
R500.000 .(16) If this is compared to the estimated cost of 
vaccinating children against measles in 1986 then 35000 children 
could be immunised for this amount of money. This is approximately 
equivalent to twice the under 1 year old population of Soweto. 
Vaccination should still be considered the most effective and 
inexpensive of available methods for preventing and controlling 
measles.
1.10. THE IMPACT OF THE VACCINE IN THE U.S.A. AND CHINA.
The United States of America and China were chosen as examples of 
the effect of vaccine in developed and developing populations.
In the United States of America prior to the introduction of live 
attenuated measles virus vaccine, 500 000 cases of measles occurred 
annually.(98) Following mass vaccination campaigns in 1966 and 
1967, the number of notified cases were 67 000, and 22 000 in 
1968 and 1969 respectively.(98) In 1976 and 1977, there was an
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increase in the number of reported cases, re. 40 000 and 5b 000. 
Unvaccinated patients accounted for 00% of these cases.(08). The 
Chinese did a study in three selected areas with large populations. 
This was analyzed over 25 years. The incidence rates of measles 
were reduced from >1,000/ 100,000 to 333/100,000 with partial use 
of vaccine and to <100/ 100,000 following the intensive use of
vaccine.(3)
1.11. THE PROMOTION OF MEASLES VACCINATION.
1.11.1. Organisations and the media.
It maybe necessary to go to extreme Jengths to ensure compliance 
with a measles vaccination schedule.(4)
Radio, television and pamphlets can help to promote awareness of 
the need to vaccinate against measles. National .Leaders, community 
networks eg. schools, religious institutions, womans' groups, 
political parties, and trade unions can be used.(99)
To have children vaccinated against measles should be seen as part 
of the social responsibility of a community.
1.11.2. Mass campaigns.
Mass campaigns and national vaccination days help to increase 
vaccination coverage.(1U0) Unless these are sustainable or repeated 
they are not considered an adequate long term measure for 
controlling measles.
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1.11.3. Gaining acceptance for the vaccination programme.
Optimal community participation is important for improving 
vaccination coverage.(101)
Nations which have achieved maximum coverage have used a 
combination of methods preferring local flexibility to rigid 
bureaucratic controls to encourage parents to have their children 
immunised against measles.(99)
The additional cost, logistical problems of administration, low 
rates of return for a second dose, the altered immunity in children 
vaccinated too early, and the loss of community support for 
programmes with high vaccine failure rates, are reasons to ensure 
effective measles vaccination during the first visit.
In South Africa measles vaccine has been available free of charge 
from the Department of Health and Population Development for more 
than 10 years. (102) Reliable delivery of viable measles vaccine 
supplies and a well-managed technical and administrative network 
are essential for optimal measles vaccination coverage.(22) 
Measles vaccination should be promoted at every health contact this 
is not possible in the Soweto community health centres at the 
moment due to the fragmentation of the health service.(16) Outreach 
services should take vaccine to those children who do not make 
regular use of the health service.(1U3)
It is usually cheaper and easier to organise vaccination programmes 
in the cities simply because it is physically easier to make 
contact with, the population.(104) Local authorities have a 
particular responsibility to ensure that 95% measles immunisation 
coverage is obtained in urban areas.
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On average, only 20% of a developing population enjoy the benefits 
of regular health care.(105) Waiting for patients to make contact 
with the health services therefore cannot be relied upon for 95% 
measles vaccination coverage. The introduction of legal 
requirements for evidence of adequate vaccination before being 
admitted to places of care or to schools would make many more 
parents and guardians aware of this need.
1.11.4. Evaluating measles vaccination coverage.
An evaluation of vaccination coverage establishes the success of 
the programme.(106,107) Epidemics can be prevented if communities 
with inadequate measles protection are identified and remedial 
action is timeousiy taken.
1.13. BACKGROUND INFORMATION ON THE DEVELOPMENT OF SOWETO AND 
ITS HEALTH SERVICES.
No report based upon measles in Soweto is complete without a brief 
description of the area and the development of the health services. 
A unique feature of the community is that developing and developed 
populations live m  close proximity to each other. The City of 
Soweto resulted from an apartheid resettlement programme of the 
Johannesburg City Council. With the discovery of gold in 1886, 
white and black migrant workers flocked to the Witwatersrand. By 
1899, the mines employed 112.OUU black workers. In 1904, there was 
an outbreak of plague and the Johannesburg local authority decided 
to address the problem of housing. Temporary dwellings were built 
near Klipspruit and the first houses were built in the South West 
"native" Township.(SOWETO) Ground was allocated on lease hold. 
This restricted people from trading in real estate and resulted in 
the inability to form neighbourhoods based upon socio-economic 
class. Even today the most elaborately built modern houses, of the 
upper socio-economic or developed classes, which would normally be 
situated in an up- market neighbourhood, are found adjacent to 
tumbled down wood and iron shacks. Hence the peculiar situation of 
having developing and developed populations living in close 
proximity to each other.
There is both a private and a government sponsored health service 
in Soweto. Health services and legislation evolved from the crisis 
of the flu epidemic in 1918. The provision of health care became 
the responsibility of the 3 levels of Government, viz. Local 
Authority, Province and State. The Local Authority provided 
promotive and preventive health services; the Province, curative 
services; and the State, forensic, laboratory and certain other 
selected health services.
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The community health centres are controlled by the Transvaal 
provincial administration, although this has not always been the 
case.
The first clinic in Soweto were started by the Johannesburg local 
authority following the appointment of Dr. Croghan, in 1927, to 
Pimville the oldest township in Soweto. The Johannesburg local 
authority was responsible for all health services in Soweto until 
1939, when the University of the Witwatersrand, with the intention 
of using the health services for teaching medical students, asked 
for a meeting with ail the health authorities. It was decided at 
this meeting that they would all co-operate under the co-ordination 
of the Local Authority to provide a comprehensive Health Service. 
The Province and State would subsidise those services which were, 
according to legislation, their responsibility. However, the 
following year, the Provincial Administration was asked to take 
over the curative health services m  order to allow the local 
authority to concentrate more on preventive health services.
In 1955, the Transvaal Provincial Administration gave notice of 
its intention to take over all detached outpatient curative health 
services. This gradually occurred over the next 10 years.
In 1980, a decision was taken to make the clinics an integral part 
of Baragwanath Hospital with an independent administration to 
manage them.
At the time of this study in 1986, there were 12 provincial 
community health centres which supplied curative services and 12 
nearby local authority clinics providing a preventive and promotive 
health service to the people of Soweto. There were approximately 
40 private medical practitioners in or on the borders of Soweto.
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2. OBJECTIVES OF THIS STUDY.
The Objectives of the study.
This study had the following objectives:
2.1 To describe the following information on measles for the Black 
population resident in Soweto for the period 1984 to 1986:
a) The annual incidence of reported cases.
b) The annual attack rates according to:
ii. Age;
ii. Residential district;
iii. Provincial curative clinics and hospitals in the area;
c) The vaccine coverage among children presenting with measles.
d) The seasonal variation in the incidence.
2.2. To make recommendations on :
a) additional information that should be collected on the 
measles notification forms.
b) further research needs on measles.
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03. METHODOLOGY.
3.1. Study design.
This is a descriptive study, based on a review of measles 
notification records.
3.2. Population.
The study population comprised all cases of measles diagnosed in 
Soweto and notified to the Johannesburg/Soweto city health 
department in the period 1 January 1984 and 31 December 1986. 
(Soweto is the geographical area known as Greater Soweto and the 
surrounding residential environs of Deepmeadow.)
3.3. Sample.
All notified cases of measles were studied; there was no sampling.
3.4. Measurements.
3.4.1.. information on measles data collection in Soweto.
The following information on how the data for measles cases is 
routinely collected will help to clarify how the data was obtained 
for this study. In terms of a regulation of the Health Act 63 of 
1972 section 32, measles is a notifiable condition and must be 
reported to the Medical Officer of Health (M.O.H.) in writing on 
a specific form number GW 17/5. The M.O.H. then informs a 
community health nurse (CHN) working at the clinic closest to the 
residential address of the patient of the measles case. This is 
done with form number M1531.(Appendix A.) The CHN visits the 
patient, parents or guardian at the residential address with the
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aim of completing form M2660 (Appendix B) which is sent back to the 
M.O.H. for information before being returned to clinic for filing. 
The information obtained on age and date of vaccination is 
confirmed by asking the patient or guardian of the child to produce 
the road to health card or any other documented proof of 
vaccination and date of birth.
When records are unavailable, the CHN's best estimate of the 
child's age is used. A child is considered vaccinated against 
measles only if documented evidence of the date of vaccination can 
be produced. A return visit to the notified address is made for 
children that cannot be contacted during the first visit.
In cases where personal contact with the patient is unsuccessful, 
neighbours or residents at the address are asked about the 
whereabouts of the notified measles cases. Patients who are known 
to be visitors, or who are unknown in the area and cannot be 
contacted are classified as non permanent residents of Soweto.
The names of all notified measles cases between 1 January 1984 and 
31 December 1986 were taken from the form used by the community 
health nurse to gather data on all notified measles cases.(M2660 
form) The names of the patients and the following data obtained 
on each patient was transferred to a data sheet, (appendix C) Date 
of birth, date of notification of measles, dates of vaccination 
against measles, residential address and name of hospital, clinic 
or health worker that notified the measles case.
3.4.2. Definition of rates.
To calculate the annual incidence rate of measles the total number 
of cases notified for each year was taken as the numerator, and the 
official Johannesburg/Soweto city council census of Black people 
resident in Soweto as the denominator. The city council calculates 
an annual census.
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3.4.3. The age specific attack rate.
Calculated from the number of children within the age group who 
were notified as having measles upon the population of that age 
group.
Birth dates, when available, were subtracted from date of measles 
notification in order to calculate the age at which measles 
occurred. It was assumed that the date of notification of disease 
was equal to the date of the disease, since measles is usually a 
disease of short duration and it is customary for the notifying 
authority to notify the disease during the first visit. In cases 
where the birth date was unknown the estimated age of the child 
as recorded by the CHN or the hospital or clinic notifying the 
patient was used.
3.4.4. The measles attack rate by residential district.
The numerator comprised all reported measles cases < 15 years of 
age who had been contacted, either at home or in hospital. The < 
15 year old population comprised 99 % of all the measles cases. 
The denominator used for each district was the official city coun­
cil census for children < 15 years of age in each respective
district in the years 1984 to 198b.
3.4.5. The measles notification rate for clinics.
The rate of notifications per clinic was calculated from the 
number of notified measles cases < 11 years of age expressed as a 
proportion of the total number of under 11 year old attendances 
for each of the clinics. The reason for using these statistics was 
that it was policy for the clinics to divide annual statistics for 
attendances into paediatric and adult attendances. Persons under 
11 are regarded as paediatric, while those 11 or more are 
classified as adults.
The under 11 year old population accounted
for 96% of all measles cases attended to by the clinics.
3.5. DATA ANALYSIS.
Ail the information on the data sheet was captured on a personal 
computer by two persons (ie. double punched) to minimise the pos­
sibility of punching errors. The data was analyzed utilizing a 
SAPEC 286 personal computer and the software packages Epi-info and 
Lotus 123.
3.6. IMPLEMENTATION.
The research was carried out in the Soweto clinics where the 
necessary records were made accessible and available through the 
good offices of the M.O.H. A professional nurse assisted with the 
transfer of information to the data sheets.
3.7. LIMITATIONS.
3.7.1. The criteria for the diagnosis of measles.
Ail notified cases were included in this study and taken as cases. 
Since it was a retrospective study it was not possible to verify 
the diagnosis.
3.7.2. The under notification of measles cases.
The assumption made that notified and incidence are similar is 
probably incorrect. Measles is known to be an under notified 
disease.(18) No measles cases were notified by any of the private 
medical practitioners working in the area.
However, as there was no reason to suspect any change in notifying 
behaviour of health workers, it is assumed that the level of 
undernotification was constant during the period.
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3.7.3. The under estimation of the population of Soweto.
There are two distinct sources of information required on 
populations before the criteria for high confidence levels and 
narrow confidence limits on epidemiological data can be achieved. 
These are:
1 . an accurate enumeration of the number, age and sex of a 
population and
ii. the occurrence of births and deaths.
For studies of this nature such requirements raise particular 
problems in Soweto. Prior to 1986, de facto population census would 
have been difficult to do, due to the lack of resources. Prior to 
and after 1985 de jure population census would have been impossible 
as inadequate records existed. Home addresses given by patients 
admitted to hospital for confinements may have been for convenience 
to avoid being refused admission on the grounds that they did not 
live in Soweto. This would have resulted in an overestimation in 
the under 1 year of age population.
During 1986, influx control regulations which controlled the inflow 
of people into Soweto were relaxed. It is not possible to exclude 
the effect this may have had on the incidence of measles in the 
area or to ascertain the accuracy of the population numbers used 
as the denominator in many of the calculations during this period.
3.7.4. Residential address.
In this study "Soweto resident" means that the patient was traced 
at the address given by the patient during the first consultation 
at the hospital or clinic. It is not equivalent to permanent 
residence in Soweto. Patients who were not found on a second visit 
or who were unknown to neighbours, were considered to be non 
residents of Soweto.
34
3.7.5. Recording errors.
The notification forms (M26bU) which were used as the data source 
had to be collected from the clinics. It was not possible to verify 
the information on the notification forms (M266U).
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04. RESULTS AND DISCUSSION.
The response rate for this study was 100% as all the forms (M2660) 
that were collected from the clinics were used. All the forms had 
been correctly completed by the community health nurse (CHN). In 
those cases where the CHN was unable to trace the patient, the 
information given to the medical officer of health (MOH) during the 
initial notification could not be verified. This occurred in less 
than 15% of cases.
The results are presented according to the objectives and reference 
is made to paragraphs in the introduction which address the issues.
4.1. THE INCIDENCE OF MEASLES.
Table 1 shows the incidence rate of measles per 100,000 <15 year 
old population from 1984 to 1986. Ninety-nine percent of all 
measles cases notified occurred in the < 15 year old population
during this period. For this reason it was decided to use the 
adjusted < 15 year old population to calculate the incidence. No 
significant difference in the incidence of measles in the Soweto 
area, was found for 1986 compared with 1984 and 1985. (t test
p=<0.001)
TABLE 1. THE MEASLES INCIDENCE RATE PER 1U0.00U POPULATION 
< 15 YEARS OF AGE FOR THE PERIOD 1984-1986.
YEAR. 1984 1985 1986
INCIDENCE 25 3 U 2 7
RATE
CASES* N = 415 N = 507 N = 464
* Number of cases
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The true incidence of measles in Soweto is likely to be greater 
than the results suggested by this study because cases were only 
notified from clinics and hospitals. The reasons why measles cases 
had not been notified by general practitioners in the area needs 
to be investigated. Under notification for measles is not unique 
to this study and has been discussed in the introduction. There 
is a need to improve notifications so that an accurate 
assessment of the incidence of measles in the area can be made. 
This is essential for planning the adequate provision of measles 
vaccine to the community.
4.2 THE ATTACK RATE ACCORDING TO AGE.
In 1986, the peak in incidence of measles for under 1 year olds 
was significantly greater than for either 1985 or 1984. (Fig 1) (t 
test p<U.0Ul) In fact the incidence of measles in the under 1 year 
old population doubled during 1986 compared to 1984 and 1985.
Age In Years
FIG.l. THE AGE SPECIFIC INCIDENCE KATE OF MEASLES IN SOWETO 
PER 100. U00 IN THE PERIOD 1984 TO 1986.
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The percentage of the total number of measles cases which were 
under 1 year of age was 15%, 13% and 30% respectively for these 3 
years.
Gibson found that 20% of South African national notifications, from 
August 1979 to July 1986, were for infants less than one year of 
age.(107) These findings are slightJy greater than the findings of 
this study for 1984 and 1985, but 10% less than that found for 
1986, the change over period to one vaccination at 9 months of age.
This could suggest that a proportion of children between 6 and 9 
months of age who were vaccinated m  1984 and 1985 were adequately 
protected against measles.
The change in the age specific attack rate, ie more measles in 
younger children, could be attributed to a greater proportion of 
6 to 9 month old children who had not been vaccinated against 
measles because of the change in policy of age of vaccination from 
6 to 9 months. They would not be protected against measles and 
would be more susceptible to the wild measles virus infection.
If there had been an epidemic of measles in 1986 then it could be 
expected that the incidence of measles in all age groups would 
have increased and the increase in incidence would not have been 
restricted to children less than one year of age. (Fig 1)
There is no reason to suspect that the ratio of children in the 
age groups, under one year, and 1 to under 15 years, would have 
changed in 198b compared to 1984 and 1985.
The increase in the incidence of measles in the under one year olds 
is therefore not attributable to an increase in population in 
that age group but rather to an increase in the attack rate.
The percentage of children under 9 months of age who contracted 
measles doubled (from 7 to 14%) in 1986 compared with the two 
previous years. (Table 11)
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TABLE 11. MEASLES CASES ACCORDING TO AGE AS A PERCENTAGE
OF ALL MEASLES CASES.
Age in months Percentage of all cases
( 1984 1985 1986
<9 7 7 14
9-15 15 13 22
The corresponding percentage increase in measles in children 9 to 
15 months of age increased from 15% in 1984 and 13% in 1985 to 22% 
in 1986. Notwithstanding the doubling of the percentage of measles 
cases in the under 9 month old group for 1986 compared with 1984 
and 1985 (7% to 14%), it is still less than that reported for other 
parts of Southern and West Africa. Loening reported that 20-45% of 
cases from an urban area in South Africa were less than 9 months 
of age while in The Gambia in 1983 measles in the under 9 month old 
group accounted for 18% of cases (18,71)
The increased rate in children of the age group 9 to 15 months in 
1986, could be ascribed to fewer children returning for vaccination 
at 9 months. After 6 months of age children are less likely to 
attend vaccination clinics.
4.2.1. Evaluating the changes in measles immunisation policy.
Changes in vaccination schedule should not go unmonitored.
In 1974 Cameroon increased the age for vaccination against measles 
from 6 to 9 months. (95) A study done in Yaounde, the capital of 
Cameroon, in 1979 showed a 40% vaccination coverage in 12 to 23 
months old children. There was a 44% decrease in reported cases of
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The greatest change occurred in the reported decrease in the 
incidence of measles in children under one year of age in the year 
following the change over to the new minimum age of vaccination at 
9 months of age while the smallest change was in the attack rate 
24 to 47 months of age.(95) There was also a decreasing trend in 
the number of children who died from measles in the Yaounde Central 
Hospital.(109) It is necessary to monitor the effects a change in 
the vaccination schedule has on the incidence and the age specific 
attack rate for future planning. Monitoring the age specific attack 
rate over three years in Soweto, during which time there was a 
change in vaccination policy is inadequate for evaluating the age 
at which measles vaccine should be given.
4.3 THE ATTACK RATE ACCORDING TO RESIDENTIAL DISTRICT.
Table IV indicates the incidence of measles by residential district 
and status. Residential status, in this case, refers to whether the 
notified measles case could be traced to the home address given 
during the initial clinic/ hospital contact and would therefore 
give an indication of whether the case lived in, or was a visitor 
to Soweto. The issue of residential status has been addressed in 
the section dealing with limitations.
In some residential districts visitors to Soweto accounted for 
100 percent of measles cases.
The incidence of measles from the districts of Soweto is not 
directly related to the incidence of measles reported in Table 1., 
which is calculated from the total number of measles cases that 
were attended to in Soweto. The latter calculation based upon all 
cases that were notified from the health services which included 
patients with residential addresses outside of Soweto.
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TABLE IV. INCIDENCE RATE OF MEASLES PER 
OLDS BY GEOGRAPHICAL DISTRICT 
OF CASES PERMANENTLY RESIDENT
100.000 UNDER 15 YEAR 
WITH THE PERCENTAGE 
IN THE DISTRICT.
DISTRICTS 1984 . 1985 . 1986 .
Incid. Res.* Incid. Res . * Incid. Res . *
ZOLA 22 50 133 75 144 92
KLIPSPRUIT 171 100 196 100 288 83
SENOANE 6 0 7 5 163 82 147 91
MOLETSANE 64 50 16 0 79 60
ZONDI 66 39 130 40 220 82
ORLANDO WEST 92 50 274 72 257 53
MOFOLO 61 75 106 72 196 85
PROTEA 107 60 214 70 156 68
PHIRI 119 0 236 75 528 11
MOLAPO 120 58 273 60 124 69
NALEDI 130 61 51 82 138 83
TLADI 132 47 232 55 292 63
ORLANDO EAST 13 5 71 217 85 178 64
JABULANI 149 60 89 6 6 118 59
JABAVU 151 0 228 57 232 49
DHLAMINI 183 83 121 7 5 120 63
EMDENI 187 70 309 7 2 138 63
CHIAWILO 260 44 82 61 163 69
MOROKO 454 80 180 60 179 70
PIMVILLE 693 75 134 86 247 62
Inc = Incidence per 100.000 under 15 year old population.
Res* = The percentage of under 15 year old population that
were in the district
In order to be able to compare the districts a rate per 100000 
population has been used in Table IV. The results of calculations 
involving small numbers of actual measles cases from each district 
are therefore magnified.
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All the measles cases from Phiri and Jabavu in 1984 and Moletsane 
in 1985 could not be traced.
Sick children from country areas are brought into Soweto for 
diagnosis and treatment. During 1984 and 1985, the period of influx 
control regulations, it is unlikely that any patient presenting at 
either a clinic or hospital without a Soweto address would have 
been attended to, unless they were acutely ill or had been referred 
from another hospital. It could be expected therefore that false 
addresses would be used by patients to get medical attention.
Certain districts did have an increased incidence rate over others 
for particular years. The range of variation in the incidence of 
measles by district is from 22 to 693 per 100 000 total population. 
This may be a reflection of discrepancies in notification of cases 
from the districts. However the socio-economic status of certain 
districts, together with overcrowding, a large susceptible 
population and inadequate health services could be responsible for 
the range in incidence. It was beyond the scope of this study to 
further investigate these findings.
In 1984 Zola had the lowest and Pimville the highest incidence of 
measles. (Table IV.) Following visits to the area it appeared, 
scientifically unconfirmed, that the socio economic status of 
Pimville was better than Zola. There are both preventive and 
curative health services in these areas. Assuming that all the 
measles cases that presented to the clinics were notified, the 
number of notification of measles cases from Zola clinic appears 
to confirm the low incidence of measles in this district during 
1984.(Fig.2. )
There was an epidemic of measles in Moroko and Pimville during 
1984. No apparent changes in the socio-economic, cultural or the 
health service delivery could obviously be linked to this 
increased incidence above other districts. More than 75% of the 
reported measles cases in both these areas were confirmed as 
permanently living there.
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Episodic epidemics have been described as occurring every 2 to 5 
years in a developing population and may account for this finding. 
However, a visitor to either or both of these districts may have 
been responsible for the introduction of wild measles virus into 
the areas. During 198b, the incidence of measles in most other 
districts of Soweto had increased while the incidence of reported 
measles cases from Pimville and Moroko decreased.
Measles in Soweto cannot be seen in isolation to measles in the 
rest of the country. Approximately 20 % of measles cases were not 
resident in Soweto. It is important that all populations at risk 
be adequately immunised against measles.
4.4 THE ATTACK RATE ACCORDING TO HOSPITALS AND CLINICS.
The percentage of measles cases notified from hospitals increased 
during 1986 compared with 1985 and 1984.(Table V)
TABLE V . The percentage of measles cases that were
notified from hospitals and clinics for the 
period 1984 to 198b.
Percentage of cases 
1984. 1985.
notified 
1986 .
Hospital/clinics
Baragwanath Hosp. 30 17 32
C.M.R. Hosp.* 16 16 28
Total from Hosp. 46 33 60
Total from Clinics 55 66 41
* C.M.R. MINES REGIONAL HOSPITAL
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The increase in the number of notified cases from hospitals during 
1986 could mean that the severity of complications among measles 
cases increased in that year compared with the previous two years 
and the complications required admission to hospital. It is known 
that measles in under one year olds is associated with more severe 
complications which require hospital admission as described in the 
introduction to this study.
The shift to an increased incidence among younger children in 
1986 has already been discussed in the paragraph dealing with the 
age specific attack rate. This accounts for the increased 
incidence of measles notified from the hospitals in 1986 and the 
perceived epidemic reported by doctors working in the referral 
hospitals in Soweto.
Patients with measles in the clinics account for up to 2.8 per 1000 
under 11 year old consultations.(Fig 2)
Incidence 3------
SE OR JA PI PH TL ZO SH CH
Cllnlo name
FIG.2. THE INCIDENCE RATE OF MEASLES BY CLINIC, PER 1000 UNDER 
11 YEAR OLD CONSULTATIONS IN THE PERIOD 1984 TO 1986. 
(SE-SENOANE, OR=ORLANDO, JA=JABAVU PI-PIMVILLE, PH=PHOMOLONG, 
TL=TLADI, ZO=ZOLA,SH=SHANTY,CH=CHIAWILO.)
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Attendance records at the clinics are kept for under 11 year 
olds. Ninety four percent of measles cases occurred in the under 
11 year old population. It was convenient to use the available 
statistics on clinic attendances for under 11 year olds to 
calculate the incidence of measles per 1000 consultations.
Besides Phomolong and Jabavu all the other clinics reported fewer 
cases of measles in 1986 compared to 1985. This could mean that in 
1986, measles cases were acutely ill and parents or guardians of 
the children decided to take their children directly to hospitals 
instead of going to the clinics.
4.5 THE VACCINATION STATUS OF MEASLES CASES.
More than 50% of notified measles cases had received at least one 
vaccination for the period 1984 to 1986.(Table VI) Only those cases 
that could provide documented proof of measles vaccination were 
considered to be vaccinated.
TABLE Vl. The vaccination status of measles cases expressed 
as a percentage of the annual number of cases.
Vaccination status.
Years.
1984. 1985. 1986.
1 X Vaccination (only)
2 X Vaccinations 
Total vaccinated 
Total unvaccinated
25 48 48 
30 24 13
55 72 61i
45 28 39
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The patients who presented with measles were divided into two 
groups, vaccinated and unvaccinated, for each of the three years 
1984 to 1986. From 1984 to 1986, a comparison of vaccinated with 
unvaccinated measles patients reveals that a greater percentage of 
measles patients had been vaccinated for each of the three years 
1984 to 1986. (Table VI)
The present method of notification and follow up of the patient 
does not record the vaccinating authority or the batch number of 
the vaccine. In this study it was not possible to determine how 
many of these patients had been vaccinated by an health authority 
other than Soweto.
Table Vll shows the age at which vaccinated children who presented 
with measles received the vaccine. In 1984 and 1985, the ratio of 
children with measles who had been vaccinated when they were less 
than 9 months of age, compared with those who had been vaccinated 
at or after 9 months of age, was greater.(55:45) This ratio was 
reversed for 1986.(39:61) Vaccine failure therefore cannot be 
ascribed entirely to the early age at which children were 
vaccinated in 1984 and 1985. Assuming that the documentation on the 
road to health chart was correct, non viable vaccine contributed 
to children being inadequately protected against measles.
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TABLE Vll.The age of vaccination of measles cases as a 
percentage of all vaccinated cases.
Age in months. The percentage of measles cases 
vaccinated
1984. 1985. 1986.
Total under 9 months 55 55 39
Total = or > 9 months 45 45 61
More than half of the notified measles cases, in this study, had 
received at least one measles vaccination. Reasons for vaccine 
failure have been discussed in the introduction (1.8.3.)
The apparent non viability of the vaccine in many of the children 
presenting with measles is a problem of concern. Calculating 
vaccine efficacy would help to determine the extent of this 
problem. However, it does not distinguish between vaccine failure 
attributable to early vaccination when maternal antibodies are 
present and inadequate maintenance of the cold chain.
Although a large percentage of measles cases had been vaccinated 
there is still an unacceptably high percentage (39%) in 1986 that 
had not. (Table Vl) Immunity levels of greater than 90% must be 
achieved before transmission of measles will be interrupted.
The ideal of 100% vaccine coverage should be strived for.(54) The 
reasons for the apparent vaccine failure in Soweto needs to be 
investigated .
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4.6 THE SEASONAL VARIATION OF MEASLES.
The seasonal variation was consistent over the three year period 
The incidence peaks in September.(Fig.3.)
Incidence
JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC
M onth o f the Year,
FIG.3. THE INCIDENCE RATE OF MEASLES CASES BY MONTH PER 100.000 
IN THE PERIOD 1984 TO 1986.
The number of measles cases starts to increase in June and July, 
during the winter months, each year. At this time children are 
likely to spend more time indoors and are therefore in closer 
contact with one another.
The seasonal incidence is not uniform throughout Africa.
In Equatorial countries Uganda, Kenya and Tanzania the peak month 
for measles is April.(4) While in Zambia, Zimbabwe and Malawi peak 
months are November to January.(110)
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West Africa reports measles throughout the year but most epidemics 
develop in the hot dry season, December to February. (4) At this 
time farm activities are reduced and festivals are held offering 
the opportunity for the spread of infection by droplets 
infections.(4) Some workers have related the increased incidence 
of measles to temperature and humidity.(Ill) Maximum survival of 
the virus does occur in the humidity found during the wet 
season.(Ill) However climatic conditions are unlikely to be an 
important factor in the spread of measles.
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5.1. The Prevention of measles.
5.1.1. In Soweto, infants from b months of age need to be protected 
against measles as shown by the increase in the incidence of 
measles in the under 9 month old population at the time of the 
change in vaccination programme from two vaccinations at 6 and 12 
months to one vaccination at 9 months.
5.1.2. Community health nurses should be involved in the planning 
of measles vaccination programmes. This would encourage them to 
maintain a high level of vaccine coverage and to make additional 
efforts to trace measles cases in their districts, to identify 
sources of infection and to commence vaccination programmes during 
the early phase of an outbreak.
5.1.3. Measles vaccination needs to be promoted. The unacceptably 
high proportion of measles cases that had not been vaccinated shows 
that awareness programmes to promote measles vaccination should be 
ongoing. In addition legislation could be changed to require that 
parents produce evidence of measles vaccination of their children 
prior to their admission to schools and creches.
5.1.4. Although on-going measles vaccination programmes in the 
clinics should be the policy for measles prevention, mass 
vaccination campaigns and a national vaccination day would help to 
promote compliance with measles vaccination. These should be 
arranged in May each year before the incidence of measles starts 
to increase. Mass vaccination campaigns and a national measles 
vaccination drive should not take priority over an ongoing process 
to promote measles vaccination.
05. RECOMMENDATIONS.
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5.2. The notification of measles cases.
5.2.1. The notification of measles cases in Soweto needs to be 
improved so that adequate planning can be done for measles vaccine 
delivery. This could be achieved by:
i. simplifying the notification procedure by accepting 
telephonic notifications.
ii. regularly contacting private family practitioners in the 
area and asking for measles notification forms.
iii. encouraging teachers, child minders and traditional healers 
to report cases to the clinics.
5.2.2. Parents should be encouraged to give accurate information 
about their residential address. They should be informed during 
their initial visit to either the clinic or hospital that a 
community health nurse will be visiting them at home during the 
first and third week of the disease to clinically reexamine the 
child, to advise on any problems that may arise and to complete a 
questionnaire on the progression of the disease.
The additional information required on notification forms.
5.2.3. Follow-up forms should include the following information if 
the reasons for vaccine failure and the cost of measles infection 
are to be investigated.
i. The place and person responsible for the measles
vaccination.
ii. The batch number of the vaccine.
iii. The suspected source of the infection if this is known. This 
is particularly important if it is suspected that the 
infection was acquired in hospital.
iv. The date of onset of complications and their nature.
v. The nature and quantity of medication that has been 
prescribed for the patient.
vi. The size of, and age of all children, in the family.
5.3. Research needs.
The following research would improve our understanding of the cost 
of measles and its prevention in Soweto.
1. The efficacy of the vaccine presently used in Soweto.
2. The establishment of the efficacy and cost efficiency of the 
aerosol of undiluted human diploid cell Zagreb strain vaccine given 
by inhalation to infants less than 9 months of age
or the Edmonston-Zagreb vaccine in a dose of 5000 plaque forming 
units given subcutaneously to 5 month old children.
3. An evaluation of the vaccination coverage in Soweto.
4. The direct costs of measles infection to the health service in 
Soweto is unknown. From the increase of measles admissions to 
hospitals in 1986 it is essential that these cost be determined. 
This would aid health planners to decide on the priority of 
improved provision of measles vaccine to the community.
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The notified incidence of measles cases in Soweto did not increase 
during the change over period from use of two immunisations at 6 
and 12 months to one immunisation at 9 months. However, the 
lowering of the age specific attack rate of measles probably 
resulted in an increase in hospital admissions. This was 
attributable to the associated increase in the occurrence of severe 
clinical complications that require admission in children with 
measles who are less than 1 year of age.
Measles in children in the Soweto community presents from 6 months 
of age. These children need to be protected against infection from 
the measles virus.
The Schwartz vaccine administered intradermally in children of 
this age group may leave them susceptible to measles infection 
later in life. They would then act as a reservoir for the wild 
measles virus which would thwart efforts to eradicate measles.
It is necessary to consider vaccines other than the Schwartz strain 
given intradermally if children between the age of 5 and 9 months 
are to protected against the wild measles virus.
Population migration resulted in a number of cases being notified 
that were temporary residents of Soweto. This emphasises the 
importance of developing a national strategy in order to prevent 
wild measles virus being reintroduced into Soweto once it had been 
eradicated.
Measles awareness campaigns are necessary, to sensitise the 
population about the importance of having children immunised 
against measles and to remind health care providers of the need to 
notify all measles cases.
06. CONCLUSIONS.
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